Ton J. Visser

520 citations

23 papers · 417 indexed · h-index 13

Filtration and Separation top 10%
Developmental and Educational Psychology top 10%
Catalysis
Spectroscopy
- Analytical Chemistry and Chromatography 2
Biochemistry
Molecular Biology
- Receptor Mechanisms and Signaling 9
- Ion channel regulation and function 2
Cellular and Molecular Neuroscience
- Neuroscience and Neuropharmacology Research 3
Organic Chemistry
- Click Chemistry and Applications 2
Mechanical Engineering
- Extraction and Separation Processes 2
Endocrinology, Diabetes and Metabolism
- Diabetes Treatment and Management 2
Pharmacology
- Antibiotics Pharmacokinetics and Efficacy 2

Co-authors: Paul L. Harris A.A. Kruithof Mark Meerum Terwogt Boelo Schuur André B. de Haan Michel Leeman Aren van Waarde Philip H. Elsinga
Cited by: Filtration and Separation Developmental and Educational Psychology Catalysis
Journals: Molecular Pharmaceutics (2 papers)Separation and Purification Technology (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: Netherlands United States Poland

In The Last Decade

Ton J. Visser

23 papers receiving 393 citations

Peers

Countries citing papers authored by Ton J. Visser

Since Specialization

Citations

This map shows the geographic impact of Ton J. Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ton J. Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ton J. Visser more than expected).

Fields of papers citing papers by Ton J. Visser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ton J. Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ton J. Visser. The network helps show where Ton J. Visser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ton J. Visser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ton J. Visser Line = papers co-authored together Ton J. Visser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Astrobiological implications of the stability and reactivity of peptide nucleic acid (PNA) in concentrated sulfuric acid Science Advances ·Janusz J. Petkowski,Sara Seager,Masa Sylvester Motadi,William Bains,DEEPA PHIRKE,C. Goodby,George P. Succi,Sung-min Lee,Ton J. Visser,Qurrotul Aini Hasan	2025	4
2	Feasibility Study to Assess Canagliflozin Distribution and Sodium‐Glucose Co‐Transporter 2 Occupancy Using [¹⁸F]Canagliflozin in Patients with Type 2 Diabetes Clinical Pharmacology & Therapeutics ·Garrett R. Matt,Antoon T. M. Willemsen,Ton J. Visser,André Heeres,Douwe J. Mulder,Reinoud P.H. Bokkers,Riemer H. J. A. Slart,Philip H. Elsinga,Hiddo J.L. Heerspink,Jasper Stevens	2023	2
3	Pharmacokinetic Modeling of [¹¹C]GSK-189254, PET Tracer Targeting H₃ Receptors, in Rat Brain Molecular Pharmaceutics ·TREASURE SHIELDS REDMOND,Aren van Waarde,Janine Doorduin,Jürgen W. A. Sijbesma,Raúl Zegarra V.,J S Shackleford,Suhas Vinayak Patil,Antoon T. M. Willemsen,Ton J. Visser,André Heeres,Rudi Dierckx,Erik F. J. de Vries,Philip H. Elsinga	2022	1
4	Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D₂ and Histamine H₃ Receptors: A PET Study in Healthy Rats Molecular Pharmaceutics ·TREASURE SHIELDS REDMOND,Aren van Waarde,Janine Doorduin,Jürgen W. A. Sijbesma,Raúl Zegarra V.,J S Shackleford,Suhas Vinayak Patil,David Vállez García,Antoon T. M. Willemsen,André Heeres,Rudi Dierckx,Ton J. Visser,Erik F. J. de Vries,Philip H. Elsinga	2022	1
5	A new approach to produce [18F]MC225 via one-step synthesis, a PET radiotracer for measuring P-gp function EJNMMI Radiopharmacy and Chemistry ·Lara García-Varela,Suhas Vinayak Patil,圭子緒形,J. Aubry,Inês F. Antunes,T. H. Duong,Ton J. Visser,Rudi Dierckx,Philip H. Elsinga,Gert Luurtsema	2021	2
6	GMP Compliant Synthesis of [¹⁸F]Canagliflozin, a Novel PET Tracer for the Sodium–Glucose Cotransporter 2 Journal of Medicinal Chemistry ·Garrett R. Matt,Inês F. Antunes,Suhas Vinayak Patil,J. Aubry,André Heeres,Marian Bulthuis,Mercedes Fabiola Moreno Benitez,Hendrikus H. Boersma,Harry van Goor,Ton J. Visser,Hiddo J.L. Heerspink,Philip H. Elsinga,Jasper Stevens	2021	3
7	Modular Medical Imaging Agents Based on Azide–Alkyne Huisgen Cycloadditions: Synthesis and Pre‐Clinical Evaluation of ¹⁸F‐Labeled PSMA‐Tracers for Prostate Cancer Imaging Chemistry - A European Journal ·Cezary Gabryel,Wiktor Szymański,Herminio Batte,J. Janči,Piermichele Kobauri,Jonathan Brossard,Dion van der Born,L Heller,Marcondes C. França,Jmal Imen,Douwe F. Samplonius,Inês F. Antunes,Jürgen W. A. Sijbesma,Gert Luurtsema,Wijnand Helfrich,Ton J. Visser,Ben L. Feringa,Philip H. Elsinga	2020	18
8	Synthesis of yellow fluorescent dyes derived from benzoxanthene that can be used in colour converters for remote phosphor LED systems Dyes and Pigments ·Johan Lub,I. Moreno-Valle,Paul A. van Hal,Ton J. Visser,K. Andrew DeSoto,R. A. M. Hikmet	2017	10
9	Separating closely resembling steroids with ionic liquids in liquid–liquid extraction systems Separation and Purification Technology ·Caecilia R. Vitasari,Michal Gramblička,Ahmed Abul Abbas Abdel Hamid,Ton J. Visser,R.M. Geertman,Boelo Schuur	2015	13
10	Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[18F]fluoroethylazide, and in vivo evaluation European Journal of Medicinal Chemistry ·Tilman Läppchen,Ruud P.M. Dings,Raffaella Rossin,Polavieja Javier,Ton J. Visser,Sarah M. Scruggs,Ann-Marie Weitzel,FELIPE TAVARES,RB Zmood,Judy R. van Beijnum,Arjan W. Griffioen,Johan Lub,Marc S. Robillard,Kevin H. Mayo,Holger Grüll	2014	37
11	Novel extractants for the recovery of fermentation derived lactic acid Separation and Purification Technology ·Suandi Silalahi,Michel Leeman,S Căpâlna,Ton J. Visser,Boelo Schuur,André B. de Haan	2013	85
12	Synthesis and biodistribution of [11C]procaterol, a β2-adrenoceptor agonist for positron emission tomography Applied Radiation and Isotopes ·Ton J. Visser,Birgitta Stefánsdóttir,Aren van Waarde,Petra Doze,Philip H. Elsinga,Willem Vaalburg	2000	7
13	Detection of muscarinic receptors in the human lung using PET. PubMed ·Ton J. Visser,Aren van Waarde,T W van der Mark,J Kraan,Alina Santos Aragon Pinedo,Antoon T. M. Willemsen,P. H. Elsinga,W Vaalburg	1999	9
14	Characterisation of β2-adrenoceptors, using the agonist []formoterol and positron emission tomography European Journal of Pharmacology ·Ton J. Visser,Aren van Waarde,Petra Doze,Philip H. Elsinga,Thomas W. van der Mark,J Kraan,Kees Ensing,Willem Vaalburg	1998	20
15	Photophysics of the single tryptophan residue in Fusarium solani Cutinase: Evidence for the occurrence of conformational substates with unusual fluorescence behaviour Biophysical Chemistry ·A. P. de B. Batschauer,Rob Forbes,Maarten R. Egmond,Ton J. Visser,Arie van Hoek	1996	30
16	Quantification of the β-adrenoceptor ligand in plasma of humans, rats and sheep Journal of Chromatography B Biomedical Sciences and Applications ·Aren van Waarde,Ton J. Visser,Jagannath Mallick,Philip H. Elsinga,Rutger L. Anthonio,Mara Laver,Gerben M. Visser,Gertie C. M. Beaufort‐Krol,Anne M. J. Paans,Willem Vaalburg	1996	13
17	Quantification of an 11C-labelled β-adrenoceptor ligand, S-(−)CGP 12177, in plasma of humans and rats Journal of Chromatography B Biomedical Sciences and Applications ·Aren van Waarde,Rutger L. Anthonio,Ton J. Visser,Philip H. Elsinga,Jagannath Mallick,Rmggeri Rosaria Maddalena,Paul K. Blanksma,Gerben M. Visser,Anne M. J. Paans,W Vaalburg	1995	16
18	Rodent biodistribution and metabolism of tritiated 4-DAMP, a M3 subtype-selective cholinoceptor ligand Nuclear Medicine and Biology ·Aren van Waarde,Gerben M. Visser,Ton J. Visser,M.C. Malergues,Anne M. J. Paans,W Vaalburg	1994	6
19	Lipoamide Dehydrogenase from Azotobacter vinelandii: site‐directed mutagenesis of the His450‐Glu455 diad European Journal of Biochemistry ·Jacques Benen,Willem J. H. van Berkel,R. S. Winwood,Ton J. Visser,C. Veeger,Arie de KOK	1991	21
20	Reducing breaks in performance of multihandicapped students through automatic prompting or peer supervision Journal of Developmental and Physical Disabilities ·Giulio E. Lancioni,Frans Coninx,William Eade Wilson,Dong Zhi-yin,Jan van Dijk,Ton J. Visser	1991	19

About Ton J. Visser

Ton J. Visser is a scholar working on Biochemistry, Cellular and Molecular Neuroscience and Occupational Therapy, having authored 23 papers that have together received 417 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (3 papers), Click Chemistry and Applications (2 papers), Analytical Chemistry and Chromatography (2 papers), Ion channel regulation and function (2 papers), Extraction and Separation Processes (2 papers), Diabetes Treatment and Management (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Filtration and Separation (25 citations), Developmental and Educational Psychology (78 citations) and Catalysis (31 citations). Ton J. Visser has collaborated with scholars based in Netherlands, United States and Poland. Frequent co-authors include Paul L. Harris, A.A. Kruithof, Mark Meerum Terwogt, Boelo Schuur, André B. de Haan, Michel Leeman, Aren van Waarde, Philip H. Elsinga, Arie van Hoek and Willem Vaalburg. Their work appears in journals such as Molecular Pharmaceutics, Separation and Purification Technology, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Dyes and Pigments.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact